A H5N1 vaccine is an influenza vaccine intended to provide immunization to influenza A virus subtype H5N1. Vaccination of poultry against the avian H5N1 influenza epizootic is widespread in certain countries.

The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, is the first adjuvanted influenza vaccine approved by FDA and is for use in people 18 years of age and older...

Jan 2, 2025 · (H5N1 is type A.) Hensley developed a vaccine candidate that can recognize all 20 of the A and B influenza subtypes—including H5N1—and found that it generated strong immune responses in mice ...

Mar 28, 2023 · Influenza Virus Vaccine, H5N1 is used to help prevent disease in people who are at risk of coming into contact with infected birds or other sources of the virus. Influenza Virus Vaccine, H5N1 is for use in adults and children who are at least 6 months old.

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is approved for use in persons (6 months and older) at increased risk of exposure to the influenza A virus H5N1 subtype contained...

May 16, 2024 · Is a vaccine available to prevent human infection with H5N1 viruses? As part of their influenza pandemic preparedness work, some countries have developed and licensed vaccines that could be used for avian influenza viruses, including H5N1.

For active immunization of persons 18 through 64 years of age at increased risk of exposure to the H5N1 influenza virus subtype contained in the vaccine.

Jul 2, 2024 · Currently, risk to human health from H5N1 is low, and vaccination is not recommended for any segment of the population. What are the safety risks associated with messenger RNA, also called mRNA, vaccines? Will mRNA …

Jan 8, 2025 · Description for Arepanrix. AREPANRIX (Influenza A [H5N1] Virus Monovalent Vaccine, Adjuvanted) is a sterile injectable emulsion for intramuscular use.The vaccine is supplied as a vial of inactivated, split-virion, A/H5N1 influenza antigen suspension and a vial of AS03 adjuvant emulsion that must be combined prior to administration.

Jul 19, 2024 · CDC has developed H5 candidate vaccine viruses (CVVs) that are nearly identical or, in many cases, identical to the hemagglutinin (HA) protein of recently detected clade 2.3.4.4b avian influenza A(H5N1) viruses in humans, birds and other mammals.